Thorne HealthTech
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Thorne HealthTech generated cash of $5,221,904, which is less than the previous year. Cash used in financing activities reached the amount of $13,356,331 last year. Net change in cash is therefore -$15,076,068.
Cash Flow
| 2019 | -7.62M | -4.19M | 11.68M |
|---|---|---|---|
| 2020 | 17.10M | -3.68M | 1.37M |
| 2021 | 9.08M | -7.17M | 38.83M |
| 2022 | 5.22M | -33.62M | 13.35M |
THRN Cash Flow Statement (2019 – 2022)
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
Cash at beginning of period | 56.00M | 15.26M | 463.64K | 587.53K |
Operating activities | ||||
Net income | 14.93M | 6.84M | -3.95M | -18.21M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 5.82M | 4.45M | 4.29M | 4.59M |
Stock-based compensation expense | 11.33M | 4.55M | 10.03M | 12.22M |
| Deferred income tax benefit | 11.33M | 4.55M | 10.03M | 12.22M |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | -8.80M | -2.88M | 2.60M | -1.56M |
Inventories | -16.75M | -12.87M | -709.51K | -7.10M |
Accounts payable | 4.43M | 6.19M | 1.06M | -590.18K |
Cash generated by operating activities | 5.22M | 9.08M | 17.10M | -7.62M |
Investing activities | ||||
Purchases Of Investments | -1M | -704.63K | 0 | 0 |
Investments In Property Plant And Equipment | -17.86M | -5.06M | -2.32M | -2.90M |
Acquisitions Net | -15.86M | -704.63K | -1.36M | -1.30M |
Cash generated by investing activities | -33.62M | -7.17M | -3.68M | -4.19M |
Financing activities | ||||
Common Stock Issued | 0 | 70M | 0 | 0 |
Payments for dividends | 0 | 0 | -3.26M | 0 |
Repurchases of common stock | -967.82K | 0 | -23.11M | 0 |
Repayments of term debt | 0 | -21.24M | -15.29M | 0 |
Cash used in financing activities | 13.35M | 38.83M | 1.37M | 11.68M |
Net Change In Cash | -15.07M | 40.73M | 14.79M | -123.88K |
Cash at end of period | 40.92M | 56.00M | 15.26M | 463.64K |
| Data source | Data source |